← 返回

外泌体作为肿瘤-免疫通讯的关键介质:对免疫治疗和液体活检的意义

英文原题:Exosomes as Pivotal Mediators of Tumor-Immune Communication: Implications for Immunotherapy and Liquid Biopsy.

查看英文原题

Exosomes as Pivotal Mediators of Tumor-Immune Communication: Implications for Immunotherapy and Liquid Biopsy.

PubMed 2026/02/24(内容时间) Int J Nanomedicine Q1 · IF 8.7(JCR 2025)

分数与星级只用于站内排序 —— 不代表疗效、安全性或个人适用性。

中文摘要

外泌体是几乎所有类型细胞分泌的膜结合囊泡,包括但不限于免疫细胞、神经元、上皮细胞和癌细胞。外泌体携带 DNA、RNA、脂质、代谢物以及细胞质和细胞表面蛋白。它们在癌症进展中的作用是动态的,与癌症类型、遗传学和分期相关。

同时,外泌体作为肿瘤免疫微环境(TME)中细胞间通讯的关键介质已引起广泛关注。这篇综合性综述描述了外泌体在肿瘤免疫生物学中的多效性作用,强调其要么促进免疫抑制、要么增强抗肿瘤免疫的双重能力。

我们系统总结了基于外泌体的免疫治疗方案的最新进展,特别强调其与已确立的治疗方式,即免疫检查点阻断和过继性细胞治疗整合时的协同疗效。

此外,我们批判性评估了用于外泌体分离和表征的新兴技术,强调它们对液体活检平台在实时免疫监测和预测性生物标志物开发中的变革性意义。本综述提出以 外泌体为中心的策略是精准免疫肿瘤学中一个范式转变的前沿,为顽固性治疗障碍提供创新性解决方案,并推动个性化肿瘤治疗的进步。

展开英文摘要原文

Exosomes are membrane-bound vesicles secreted by almost all types of cells, including but not limited to immune cells, neurons, epithelial cells, and cancer cells. Exosomes carry DNA, RNA, lipids, metabolites, as well as cytoplasmic and cell surface proteins. Their role in cancer progression is dynamic and is related to the type of cancer, genetics, and stage.

At the same time, exosomes have attracted widespread attention as key mediators of intercellular communication in the tumor immune microenvironment (TME). This comprehensive review delineates the pleiotropic roles of exosomes in tumor immunobiology, emphasizing their bimodal capacity to either foster immunosuppression or potentiate antitumor immunity.

We systematically synthesize recent advancements in exosome-based immunotherapeutic regimens, with particular emphasis on their synergistic efficacy when integrated with established modalities, namely immune checkpoint blockade and adoptive cellular therapy.

Furthermore, we critically appraise emergent technologies for exosome isolation and characterization, underscoring their transformative implications for liquid biopsy platforms in real-time immune surveillance and the development of predictive biomarkers. This review posits exosome-centric strategies as a paradigm-shifting frontier in precision immuno-oncology, furnishing innovative remedies for recalcitrant therapeutic hurdles and propelling the advancement of personalized oncology care.

论文信息

作者
Wei M、Wang D、Xu W、Zang X、Jiang J
单位
Aoyang Institute of Cancer, Center of Clinical Laboratory, Affiliated Aoyang Hospital of Jiangsu University, Suzhou, Jiangsu, 215600, People's Republic of China.China
文献类型
综述
期刊
International journal of nanomedicine2026
原文标识
PubMed 41773242 · DOI 10.2147/IJN.S583756